Suptavumab
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Suptavumab, covering 2018-11-06 to 2018-11-06. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Suptavumab (REGN2222) for the Prevention of Medically Attended RSV (Respiratory Syncytial Virus) Infection in Preterm Infants [Phase 3]